Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MNPR
#2657
Monopar Therapeutics Inc. - Common Stock
111.8
9
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.80%
Monthly Change
+3.63%
6 month change
+110.04%
Year Change
+104.85%
Previous Close
113.9
4
Open
111.8
9
Low
111.8
9
High
111.8
9
Volume
23
Markets
US Stock Market
Healthcare
Biotechnology
MNPR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
2.51 M
2.52 M
2.64 M
3.49 M
6.11 M
6.69 M
6.71 M
Valuation ratios
Enterprise value
60.17 M
20.16 M
22.42 M
-807.76 K
88.66 M
375.16 M
704.05 M
Price to earnings ratio
—
—
-2.81
-0.61
-5.35
-35.28
—
Price to sales ratio
—
—
1 389.24
11.92
—
—
—
Price to cash flow ratio
—
—
-4.08
-0.65
-13.02
-39.66
—
Price to book ratio
—
—
2.92
0.92
1.52
3.51
—
Enterprise value to EBITDA ratio
—
—
—
—
—
-21.54
—
Profitability ratios
Return on assets %
-0.37
-0.44
-0.8
-1.14
-0.26
-0.1
-0.04
Return on equity %
-0.4
-0.48
-1.04
-1.5
-0.28
-0.1
-0.04
Return on invested capital %
-27.15 K
-42.46 K
-51.3 K
-95.64 K
-1.02 M
-437.52
—
Gross margin %
100
100
-291.89
100
—
—
—
Operating margin %
-7 947.15
-37.99 K
-49.61 K
-2 058.38
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-7 697.7
-37.89 K
-49.51 K
-1 958.38
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.28
12.19
4.21
4.17
26.74
51.35
33.56
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0
0
0.04
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.84
-2.84
-1.69
-1.65
-1.78
EBIT per share
—
—
-4.17
-3.04
-4.26
-2.25
—
EBITDA per share
—
—
—
—
—
-2.35
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.79
5
24.1
16.56
12.34
Net current asset value per share
—
—
5.18
2.65
15.91
18.95
15.78
Tangible book value per share
—
—
3.97
2.02
14.52
18.6
15.32
Working capital per share
—
—
3.95
2.02
15.31
18.58
15.31
Book value per share
—
—
3.97
2.02
14.52
18.6
15.32
News
Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’
Prime Medicine: An Initial Prognosis (NASDAQ:PRME)
Monopar Stock: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy) (NASDAQ:MNPR)
Monopar Therapeutics: ALXN1840's Bull Case Has Improved (NASDAQ:MNPR)
Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade
Monopar names Susan Rodriguez as chief commercial officer
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Monopar Therapeutics stock rating reiterated by Cantor Fitzgerald
BTIG reiterates Buy rating on Monopar Therapeutics stock ahead of NDA submission
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating
Raymond James reiterates Outperform rating on Monopar stock amid FDA meeting uncertainty
Monopar therapeutics CFO Vu Quan Anh buys $104925 in shares